反応式
[CH3:1][O:2][C:3]1[CH:25]=[C:24]([O:26][CH3:27])[CH:23]=[CH:22][C:4]=1[CH2:5][N:6]([CH2:18][C@@H:19](O)[CH3:20])[C:7](=[O:17])[C@@H:8]([NH:10][C:11](=[O:16])[C:12]([F:15])([F:14])[F:13])[CH3:9].C1(OP(OC2C=CC=CC=2)(OC2C=CC=CC=2)=O)C=CC=CC=1.N(C(OCC)=O)=NC(OCC)=O>O1CCCC1>[CH3:1][O:2][C:3]1[CH:25]=[C:24]([O:26][CH3:27])[CH:23]=[CH:22][C:4]=1[CH2:5][N:6]1[CH2:18][C@@H:19]([CH3:20])[N:10]([C:11](=[O:16])[C:12]([F:14])([F:13])[F:15])[C@@H:8]([CH3:9])[C:7]1=[O:17]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
(2S, 2S)-N-(2,4-Dimethoxy-benzyl)-N-(2-hydroxypropyl)-2-(2,2,2-trifluoroacetylamino)-propionamide (3.64 g, 9.29 mmol) is dissolved in 25 mL of tetrahydrofuran. Triphenylphosphate (3.65 g, 14.0 mmol) is added, and the resulting mixture is cooled to 0° C. before diethyl azodicarboxylate (2.2 mL, 14 mmol) is added slowly. The resulting mixture is left to stir overnight. The reaction mixture is condensed, and the residue is purified by column chromatography (SiO2, 25% ethyl acetate/hexane). The desired product, (3S, 5R)-1-(2,4-dimethoxy-benzyl)-3,5-dimethyl-4-trifluoroacetyl-piperazin-2-one (1.5 g, 43% yield), is isolated as a clear oil.
後処理
- additionis added slowly
- waitThe resulting mixture is left
- customcondensed
- customthe residue is purified by column chromatography (SiO2, 25% ethyl acetate/hexane)
出典と根拠
- ORDレコード
- ord-d0c248c53bfe4d62a63af17d0d0d2e4c
- 出典データセット
- uspto-grants-2009_11
- 特許番号
- US07612075B2
関連ノート
読み込み中…